{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-024101","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2026-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.050774+00:00","generated_at":"2026-05-15T07:06:11.304657+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ginkgo completes sale of Biosecurity segment to Tower Biosecurity, retains 20% stake","bullets":["On April 3, 2026, Ginkgo contributed all Biosecurity equity to Tower Biosecurity (Perimeter Systems) for ~20% of buyer's fully diluted shares.","Biosecurity will be reported as discontinued operations starting Q1 2026; pro forma results show reduced operating losses.","Pro forma 2025 net loss improved to $287.8M from $312.8M; 2024 loss improved to $507.6M from $547.0M.","The retained 20% stake will be equity-method accounted; preliminary valuation of $12.3M.","Ginkgo and Tower entered a Transition Services Agreement for temporary services."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-024101","json":"https://secwatch.observer/filing/0001628280-26-024101.json","markdown":"https://secwatch.observer/filing/0001628280-26-024101.md","text":"https://secwatch.observer/filing/0001628280-26-024101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024101/0001628280-26-024101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024101/dna-20260403.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:06:11.304657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39040bf77a978bddb5025244a0a8418f58a4d462","claim":"Ginkgo Bioworks Holdings, Inc. completed a disposition involving Tower Biosecurity, Inc. also known as Perimeter Systems, Inc. (closed 2026-04-03).","evidence_excerpt":"On April 3, 2026, Ginkgo Bioworks, Inc. (the \"Seller\"), a wholly owned subsidiary Ginkgo Bioworks Holdings, Inc. (the \"Company\") completed the previously announced transaction (the \"Transaction\") with Tower Biosecurity, Inc. also known as Perimeter Systems, Inc. (the \"Purchaser\") pursuant to the Stock Purchase Agreement, dated as of February 26, 2026 (the \"Purchase Agreement\"), by and among the Seller, the Company, the Purchaser and Ginkgo Biosecurity, LLC (\"Biosecurity\").","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024101/0001628280-26-024101-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Tower Biosecurity, Inc. also known as Perimeter Systems, Inc."},{"label":"Closing","value":"2026-04-03"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}